scispace - formally typeset
D

Dimitra Klapsa

Researcher at National Institute for Biological Standards and Control

Publications -  18
Citations -  426

Dimitra Klapsa is an academic researcher from National Institute for Biological Standards and Control. The author has contributed to research in topics: Poliovirus & Medicine. The author has an hindex of 6, co-authored 12 publications receiving 222 citations.

Papers
More filters
Journal ArticleDOI

Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic

TL;DR: It is concluded that viral RNA sequences found in sewage closely resemble those from clinical samples and that environmental surveillance can be used to monitor SARS-CoV-2 transmission, tracing virus variants and detecting virus importations.
Journal ArticleDOI

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.

TL;DR: The results in virus neutralization assays with human sera and immunisation-challenge experiments using transgenic mice expressing the human poliovirus receptor indicate that while maintaining high immunisation coverage will likely confer protection against paralytic disease caused by these viruses, significant changes in immunisation strategies might be required to effectively stop their occurrence and potential widespread transmission.
Journal ArticleDOI

Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.

TL;DR: In this article, the authors investigated the use of environmental surveillance (ES) for the rapid detection and quantification of B.1.7 viruses in sewage as a way of monitoring its expansion that is independent on the investigation of identified clinical cases.
Journal ArticleDOI

Isolation of Vaccine-Like Poliovirus Strains in Sewage Samples From the United Kingdom.

TL;DR: A novel ES approach using next-generation sequencing (NGS) to identify HEVs in sewage samples collected in London, United Kingdom, from June 2016 to May 2017 has high sensitivity for polio and non-PV HEV detection, generating nearly whole-genome sequence information.